DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Scirica BM, Bonaca MP, Braunwald E. , et al; TRA 2°P-TIMI 50 Steering Committee Investigators.
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.
Lancet 2012;
380 (9850): 1317-1324
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.